Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

35.98

-0.31 (-0.85%)

Jul 30, 2026, 4:00 PM EDT - Market closed

Collegium Pharmaceutical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	796.33	780.57	631.45	566.77	463.93	276.87
Revenue Growth	19.88%	23.61%	11.41%	22.17%	67.56%	-10.69%
Gross Profit	483.18	463.26	377.34	326.17	209.49	150.62
Operating Income	188.85	179.64	169.9	166.96	33.32	17.63
Net Income	74.95	62.87	69.19	48.16	-25	71.52
Earnings Per Share	2.04	1.73	1.86	1.29	-0.74	1.86
EPS Growth	67.21%	-6.99%	44.19%	-	-	144.74%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	421.75	386.68	162.76	310.55	173.69	186.43
Total Debt	929.69	936.43	979.91	674.28	709.18	258.75
Net Cash (Debt)	-507.94	-549.75	-817.15	-363.74	-535.49	-72.32
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-12.81	-13.85	-20.21	-8.70	-15.83	-1.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	331.04	329.32	204.98	274.75	124.23	103.56
Capital Expenditures	-1.21	-1.74	-1.65	-0.46	-1.62	-1.94
Free Cash Flow	329.83	327.58	203.33	274.29	122.61	101.61
Free Cash Flow Growth	67.80%	61.11%	-25.87%	123.71%	20.66%	14.95%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	60.68%	59.35%	59.76%	57.55%	45.15%	54.40%
Operating Margin	23.71%	23.01%	26.91%	29.46%	7.18%	6.37%
Pretax Margin	13.59%	11.87%	15.61%	13.36%	-6.22%	-1.22%
Profit Margin	9.41%	8.05%	10.96%	8.50%	-5.39%	25.83%
FCF Margin	41.42%	41.97%	32.20%	48.40%	26.43%	36.70%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	21.94	26.76	15.40	23.86	-	10.04
Forward PE	4.63	6.11	4.54	5.57	4.01	4.57
P/FCF Ratio	3.54	4.48	4.43	3.58	6.40	6.19
PS Ratio	1.47	1.88	1.43	1.73	1.69	2.27